Skip to main content
Signal8

Reumuth Mary

SEC insider (Form 3/4/5 filer). CIK 0001710969. CHIEF FINANCIAL OFFICER at KALA BIO, Inc. (KALA). 6 reported Form 4/5 transactions since Sep 2024; latest on Oct 23, 2025. Located in ARLINGTON, MA.

Companies Reumuth Mary has filed insider reports for

  • KALA BIO, Inc. (KALA): Officer, CHIEF FINANCIAL OFFICER
Reumuth Mary profile photo

Reumuth Mary

CIK: 0001710969

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)5 (83.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (16.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

KALA BIO, Inc. logo
KALA

KALA BIO, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • KALA BIO, Inc. logo
    KALA

    KALA BIO, Inc.

    Oct 23, 2025
    Sale
    Direct
    967 shares at avg. $0.82$792.94
  • KALA BIO, Inc. logo
    KALA

    KALA BIO, Inc.

    Oct 22, 2025
    Sale
    Direct
    32.2K shares at avg. $0.83$27K
  • KALA BIO, Inc. logo
    KALA

    KALA BIO, Inc.

    Jun 24, 2025
    Sale
    Direct
    3.6K shares at avg. $4.01$15K
  • KALA BIO, Inc. logo
    KALA

    KALA BIO, Inc.

    Jun 3, 2025
    Sale
    Direct
    2.9K shares at avg. $3.74$11K
  • KALA BIO, Inc. logo
    KALA

    KALA BIO, Inc.

    Jan 6, 2025
    Award
    Direct
    10.1K shares-
  • KALA BIO, Inc. logo
    KALA

    KALA BIO, Inc.

    Jan 6, 2025
    Sale
    Direct
    1.7K shares at avg. $7.63$13K

1-6 of 6